Pulmonx Corporation

LUNGNASDAQHealthcare● Active

$1.49

$-0.04(-2.61%)

Market Cap$62933428

P/E Ratio—

52W High$3.88

52W Low$1.13

Avg Volume440K

Open$1.59

Beta0.28

Overview

Pulmonx Corporation (LUNG) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · LUNG · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.02

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 2%Active transactions only · RSU vesting excluded98% Sell ↓

Pulmonx Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

LUNG insider buying and selling by quarter

LUNG insider selling · LUNG insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

3.6M1.8M0

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · LUNG ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

LUNG executive sell shares · LUNG board member insider trading · LUNG insider trading SEC filing

Showing 89 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Mar 2, 2026	Radhakrishnan Srikanth Chief Science &Techn. Officer	Award	175,000	—	—	345,736	Form 4
Mar 2, 2026	Radhakrishnan Srikanth Chief Science &Techn. Officer	Sale	756	$1.43	$1K	180,463	Form 4
Mar 2, 2026	Radhakrishnan Srikanth Chief Science &Techn. Officer	Sale	3,068	$1.43	$4K	177,395	Form 4
Mar 2, 2026	Radhakrishnan Srikanth Chief Science &Techn. Officer	Sale	2,461	$1.43	$4K	174,934	Form 4
Mar 2, 2026	Radhakrishnan Srikanth Chief Science &Techn. Officer	Sale	4,198	$1.43	$6K	170,736	Form 4
Mar 2, 2026	French Glendon E. III President and CEO · Director	Sale	2,708	$1.43	$4K	1,474,616	Form 4
Mar 2, 2026	French Glendon E. III President and CEO · Director	Sale	6,737	$1.43	$10K	1,467,879	Form 4
Mar 2, 2026	French Glendon E. III President and CEO · Director	Sale	58,368	$1.43	$83K	1,409,511	Form 4
Mar 2, 2026	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Award	100,000	—	—	465,734	Form 4
Mar 2, 2026	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Sale	835	$1.43	$1K	372,631	Form 4
Mar 2, 2026	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Sale	2,125	$1.43	$3K	370,506	Form 4
Mar 2, 2026	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Sale	1,861	$1.43	$3K	368,645	Form 4
Mar 2, 2026	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Sale	2,911	$1.43	$4K	365,734	Form 4
Mar 2, 2026	Lehman David Aaron GENERAL COUNSEL	Award	150,000	—	—	390,755	Form 4
Mar 2, 2026	Lehman David Aaron GENERAL COUNSEL	Sale	1,163	$1.43	$2K	251,829	Form 4
Mar 2, 2026	Lehman David Aaron GENERAL COUNSEL	Sale	4,433	$1.43	$6K	247,396	Form 4
Mar 2, 2026	Lehman David Aaron GENERAL COUNSEL	Sale	2,590	$1.43	$4K	244,806	Form 4
Mar 2, 2026	Lehman David Aaron GENERAL COUNSEL	Sale	4,051	$1.43	$6K	240,755	Form 4
Dec 8, 2025	Florin Daniel P Director	Sale	23,321	$1.99	$46K	93,910	Form 4
Dec 1, 2025	French Glendon E. III President and CEO · Director	Award	1,200,000	—	—	1,477,324	Form 4
Dec 1, 2025	French Glendon E. III President and CEO · Director	Sale	2,524	$1.57	$4K	283,605	Form 4
Dec 1, 2025	French Glendon E. III President and CEO · Director	Sale	6,281	$1.57	$10K	277,324	Form 4
Dec 1, 2025	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Sale	683	$1.57	$1K	379,105	Form 4
Dec 1, 2025	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Sale	1,738	$1.57	$3K	377,367	Form 4
Dec 1, 2025	Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER	Sale	1,522	$1.57	$2K	375,845	Form 4

Radhakrishnan Srikanth

Chief Science &Techn. Officer

Award

Date

Mar 2

175,000

Price

—

Value

—

View Form 4 on SEC.gov

Radhakrishnan Srikanth

Chief Science &Techn. Officer

Sale

Date

Mar 2

756

Price

$1.43

Value

$1K

View Form 4 on SEC.gov

Radhakrishnan Srikanth

Chief Science &Techn. Officer

Sale

Date

Mar 2

3,068

Price

$1.43

Value

$4K

View Form 4 on SEC.gov

Radhakrishnan Srikanth

Chief Science &Techn. Officer

Sale

Date

Mar 2

2,461

Price

$1.43

Value

$4K

View Form 4 on SEC.gov

Radhakrishnan Srikanth

Chief Science &Techn. Officer

Sale

Date

Mar 2

4,198

Price

$1.43

Value

$6K

View Form 4 on SEC.gov

French Glendon E. III

President and CEO · Director

Sale

Date

Mar 2

2,708

Price

$1.43

Value

$4K

View Form 4 on SEC.gov

French Glendon E. III

President and CEO · Director

Sale

Date

Mar 2

6,737

Price

$1.43

Value

$10K

View Form 4 on SEC.gov

French Glendon E. III

President and CEO · Director

Sale

Date

Mar 2

58,368

Price

$1.43

Value

$83K

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Award

Date

Mar 2

100,000

Price

—

Value

—

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Sale

Date

Mar 2

835

Price

$1.43

Value

$1K

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Sale

Date

Mar 2

2,125

Price

$1.43

Value

$3K

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Sale

Date

Mar 2

1,861

Price

$1.43

Value

$3K

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Sale

Date

Mar 2

2,911

Price

$1.43

Value

$4K

View Form 4 on SEC.gov

Lehman David Aaron

GENERAL COUNSEL

Award

Date

Mar 2

150,000

Price

—

Value

—

View Form 4 on SEC.gov

Lehman David Aaron

GENERAL COUNSEL

Sale

Date

Mar 2

1,163

Price

$1.43

Value

$2K

View Form 4 on SEC.gov

Lehman David Aaron

GENERAL COUNSEL

Sale

Date

Mar 2

4,433

Price

$1.43

Value

$6K

View Form 4 on SEC.gov

Lehman David Aaron

GENERAL COUNSEL

Sale

Date

Mar 2

2,590

Price

$1.43

Value

$4K

View Form 4 on SEC.gov

Lehman David Aaron

GENERAL COUNSEL

Sale

Date

Mar 2

4,051

Price

$1.43

Value

$6K

View Form 4 on SEC.gov

Florin Daniel P

Director

Sale

Date

Dec 8

23,321

Price

$1.99

Value

$46K

View Form 4 on SEC.gov

French Glendon E. III

President and CEO · Director

Award

Date

Dec 1

1,200,000

Price

—

Value

—

View Form 4 on SEC.gov

French Glendon E. III

President and CEO · Director

Sale

Date

Dec 1

2,524

Price

$1.57

Value

$4K

View Form 4 on SEC.gov

French Glendon E. III

President and CEO · Director

Sale

Date

Dec 1

6,281

Price

$1.57

Value

$10K

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Sale

Date

Dec 1

683

Price

$1.57

Value

$1K

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Sale

Date

Dec 1

1,738

Price

$1.57

Value

$3K

View Form 4 on SEC.gov

Rose Geoffrey Beran

CHIEF COMMERCIAL OFFICER

Sale

Date

Dec 1

1,522

Price

$1.57

Value

$2K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About LUNG insider trading

LUNG insider trades

Pulmonx Corporation (LUNG) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER), Lehman David Aaron (GENERAL COUNSEL), French Glendon E. III (President and CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. LUNG insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Pulmonx Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

LUNG insider trading · 5 questions

The insiders of Pulmonx Corporation (LUNG) include executives and directors such as Rose Geoffrey Beran (CHIEF COMMERCIAL OFFICER), Lehman David Aaron (GENERAL COUNSEL), French Glendon E. III (President and CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

LUNG board member insider tradingwho are LUNG insidersLUNG insider rosterPulmonx Corporation executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026